The HemOnc Pulse cover image

Graham Collins, MBBS, on New Agents, Prognostic Models in Hodgkin Lymphoma

The HemOnc Pulse

00:00

Early Stage Hodgkin Disease - Is There a Future?

There's an ongoing large, randomized study in early stage Hodgkin disease. So it's looking at a squared VD approach in early stage disease. The primary endpoint is an improvement in PFS. It's not non-inferiority. It's actually a superiority study. And of course, it's also looking to see if we can further reduce radiotherapy in the group that you're right. I mean, radiotherapy is used fairly sparingly already.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app